Verus Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Verus Capital Partners's JNJ Position: Q2 2026 in Review
Verus Capital Partners increased its Johnson & Johnson (JNJ) stake by 3.2% in Q2 2026, buying an estimated $54.8K and bringing the position to 7,570 shares worth $1.92M. The position accounts for 0.1% of the portfolio, ranked #128.
Verus Capital Partners first reported a position in JNJ in Q4 2019 and has held it in 20 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Verus Capital Partners held 7,570 shares of Johnson & Johnson worth $1.92M as of Q2 2026.
- Verus Capital Partners bought 235 Johnson & Johnson shares in Q2 2026, an estimated $54.8K.
- Johnson & Johnson made up 0.1% of Verus Capital Partners's portfolio in Q2 2026, its #128 holding.
- Verus Capital Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 20 quarters since.
- 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.